Carl Zeiss Meditec stock | Price target for 2026, price & analyst rating

Carl Zeiss Meditec

XTRA:AFX

€ 25,94

+ €0,42 (1,65%)

25,94 €

+€0,42 (1,65%)

End-of-day quote: 04/10/2026

Carl Zeiss Meditec Stock Value

The analyst rating for XTRA:AFX is currently Hold.

Hold

Carl Zeiss Meditec Company Info

EPS Growth 5Y

4,50%

Market Cap

€2,27 B

Long-Term Debt

€0,40 B

Quarterly earnings

N/A

Dividend

€0,56

Dividend Yield

2,16%

Founded

1846

Industry

Health Care

Country

Germany

Website

Carl Zeiss Meditec

ISIN Number

DE0005313704

Website

http://www.zeiss.com/meditec-ag/de/investor-relations.html?vaURL=www.zeiss.de/meditec-ag/ir

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

€30,00

15.65%

Last Update: 04/11/2026

Analysts: 14

Highest Price Target €50,00

Average Price Target €30,00

Lowest Price Target €22,40

In the last five quarters, Carl Zeiss Meditec’s Price Target has fallen from €226,00 to €103,87 - a -54,04% decrease. Ten analysts predict that Carl Zeiss Meditec’s share price will increase in the coming year, reaching €30,00. This would represent an increase of 15,65%.

Top growth stocks in the health care sector (5Y.)

What does Carl Zeiss Meditec do?

Carl Zeiss Meditec AG operates primarily in the medical technology sector. The company develops medical devices, solutions, and technologies that cater to healthcare professionals around the globe. The company specializes in areas such as ophthalmology, microsurgery, and extended digital solutions, effectively combining hardware with software to deliver precision and accuracy in medical procedures. Business Segments The company operates through two primary business segments, each with speciali...

Business Segments

The company operates through two primary business segments, each with specialized focus areas: Ophthalmology and Surgical.

Ophthalmology

This segment is dedicated to improving patient care through advanced diagnostic and surgical solutions tailored for eye care professionals. This segment encompasses an array of products, including diagnostic devices such as optical coherence tomography (OCT) systems and visual field analyzers, which facilitate precise diagnosis and monitoring of various eye conditions. The ophthalmic surgical solutions offered by the company include phacoemulsification systems and intraocular lenses used in cataract surgeries.

Surgical Segment

This segment focuses on providing high-precision optical systems for a multitude of surgical applications, emphasizing the integration of innovative technologies into surgical workflows. This segment produces surgical microscopes, visualization systems, and intraoperative imaging solutions that enhance the performance of surgeons across disciplines such as neurosurgery, spinal surgery, and ENT (ear, nose, and throat) procedures.

Business Strategy

This segment employs a proactive business strategy centered on innovation, market expansion, and customer engagement. The company's commitment to research and development drives product innovation, enabling it to stay ahead of competitors in the rapidly evolving medical technology landscape.

Another key element of the company's strategy involves diversifying its product offerings to cater to a broader customer base. The company seeks to expand its influence in the global market while remaining adaptable to region-specific demands. The company employs a robust feedback loop, integrating insights from healthcare providers and patients to enhance product design and user interfaces.

Additionally, strategic partnerships and acquisitions play a pivotal role in the company's growth strategy, allowing for accelerated access to new markets and technologies. Through well-timed acquisitions, the company enhances its technological capabilities and broadens its product portfolio, ensuring ongoing relevance within the sector.

Products and Services

The company offers a range of products and services designed to meet the needs of healthcare professionals across its primary business segments: Ophthalmology and Surgical.

Ophthalmology Products and Services

Within the Ophthalmology segment, the company's product portfolio includes advanced diagnostic systems such as optical coherence tomography (OCT) for in-depth analysis of retinal structures and visual field analyzers that assist in identifying visual field deficits. These devices are complemented by surgical technologies like the FEMTO Laser for cataract surgeries and a variety of intraocular lenses tailored for specific patient needs. The company also provides support services such as training, maintenance, and technical assistance to ensure that healthcare professionals can maximize the effectiveness of their investments in technology.

Surgical Products and Services

In the Surgical segment, the company specializes in high-precision surgical microscopes and imaging systems that enhance the visual capabilities of surgeons during intricate procedures. The company's product offerings include the KINEVO® 900 and OPMI® series of surgical microscopes, designed to improve visualization in procedures across various disciplines, including neurosurgery and otolaryngology. Moreover, the company provides integrated software solutions that facilitate seamless communication and image integration in the operating room, boosting the overall efficiency and precision of surgical workflows.

Geographical Markets Served

The company operates in an array of geographical markets, extending its products and services globally. Key markets include Europe, North America, and Asia-Pacific, with each region representing significant segments of the company's customer base.

In Europe, the focus is on consolidating market leadership through continuous innovation in product development, well-established distribution channels, and direct partnerships with healthcare professionals. North America represents a rapidly growing market, where the demand for advanced medical technology is soaring. The Asia-Pacific region is seen as a vital growth avenue, with emerging economies increasingly investing in healthcare improvements.

Seasonality

The company's operations exhibit some degree of seasonality, although the company endeavors to mitigate these fluctuations through strategic planning and initiatives. The company actively monitors market conditions and customer behaviors to adjust its sales strategies, accordingly, ensuring a consistent flow of products and services to meet demand peaks.

Customers

The company serves a clientele, comprising healthcare professionals, hospitals, and medical clinics globally. The customer categories include ophthalmologists, surgeons, and other specialists within the medical field who require advanced medical devices and solutions.

Sales and Marketing

The company utilizes a multi-faceted approach for sales and marketing, focusing on building strong relationships with healthcare professionals and institutions. The company also participates in international medical fairs and conferences, showcasing its latest innovations and fostering connections with potential clients. By maintaining communication with clients through newsletters, webinars, and online content, the company reinforces its brand presence and educates stakeholders about its comprehensive offerings.

History

Carl Zeiss Meditec AG was founded in 1846.

Carl Zeiss Meditec Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Revenue distribution by sectors:** - Ophthalmology: approx. 70% - Microsurgery: approx. 30% **TOP 3 markets:** - USA: approx. 35% - Germany: approx. 20% - China: approx. 15% Carl Zeiss Meditec AG generates the majority of its revenue from ophthalmology, highlighting the importance of this segmen...

At which locations are the company’s products manufactured?

**Production Sites:** - Germany (Jena, Oberkochen) - USA - France - Spain - China Carl Zeiss Meditec AG produces its products at several international locations. In Germany, there are significant production facilities in Jena and Oberkochen, known for their highly precise optical and medical device...

What strategy does Carl Zeiss Meditec pursue for future growth?

**Focus on Innovation and Technological Development** **Expansion of Market Presence in Asia** **Expansion of Digital Offerings** Carl Zeiss Meditec AG strongly emphasizes innovation and the development of new technologies to secure its future growth. The company continuously invests in research...

Which raw materials are imported and from which countries?

**Main materials:** Glass, plastic, metals **Countries of origin:** Germany, Japan, USA, China Carl Zeiss Meditec AG is a leading provider of medical technology and optical products. For the production of their products, the company imports various raw materials and materials. Glass and special op...

How strong is the company’s competitive advantage?

**Market Share:** 12% in the field of Ophthalmology (2024) **R&D Expenses:** 13% of revenue (2024) **Gross Margin:** 58% (2024) Carl Zeiss Meditec AG has a significant competitive advantage, especially in the field of Ophthalmology and microsurgery. The company benefits from a strong brand...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** Approximately 60% (2025, estimated) **Insider Buys/Sells:** No significant transactions in the last year (2024) The institutional investor share in Carl Zeiss Meditec AG is estimated to be around 60%. This high participation suggests that the company is considered...

What percentage market share does Carl Zeiss Meditec have?

**Market share of Carl Zeiss Meditec AG:** 12% (2025, estimated) **Main competitors and their market shares:** 1. Alcon Inc. - 18% 2. Bausch + Lomb Corporation - 15% 3. Johnson & Johnson Vision - 14% 4. Carl Zeiss Meditec AG - 12% 5. EssilorLuxottica - 10% 6. Hoya Corporation - 8% 7. CooperVisi...

Is Carl Zeiss Meditec stock currently a good investment?

**Revenue Growth:** 8% (2024) **Profit Growth:** 10% (2024) **Research and Development Ratio:** 13% of revenue (2024) Carl Zeiss Meditec AG recorded solid revenue growth of 8% in 2024, driven by strong demand for their innovative medical technologies. The company also achieved a profit growth of 10...

Does Carl Zeiss Meditec pay a dividend – and how reliable is the payout?

**Dividend yield:** 1.2% (2024) **Dividend growth:** 5% (last 3 years) Carl Zeiss Meditec AG has regularly distributed dividends in recent years, with the dividend yield standing at approximately 1.2% in 2024. The company has maintained a consistent dividend growth of an average of 5% per year over...

New support ticket

Explore

Carl Zeiss Meditec Stock Value

Carl Zeiss Meditec Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Carl Zeiss Meditec do?

Carl Zeiss Meditec Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Carl Zeiss Meditec Stock Value

Carl Zeiss Meditec Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Carl Zeiss Meditec do?

Carl Zeiss Meditec Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.